• 1

    Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int 2012; 2(Suppl):279335.

    • Search Google Scholar
    • Export Citation
  • 2

    Stancu S, et al.. Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? Clin J Am Soc Nephrol 2010; 5:409416.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3

    National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47:S1S146.

    • Search Google Scholar
    • Export Citation
  • 4

    Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 1990; 300:573578.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5

    Besarab A, et al.. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584590.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6

    Parfrey PS, et al.. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 2005; 16:21802189.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7

    Drueke TB, et al.. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355:20712084.

  • 8

    Singh AK, et al.. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355:20852098.

  • 9

    Pfeffer MA, et al.. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361:20192032.

  • 10

    Lewis EF, et al.. Darbepoetin alfa impact on health status in diabetes patients with kidney disease; a randomized trial. Clin J Am Soc Nephrol 2011; 6:845855.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11

    Solomon SD, et al.. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 2010; 363:11461155.

Highlights of Kidney Disease: Improving Global Outcomes Clinical Practice Guidelines for Anemia in Chronic Kidney Disease

Restricted access
Save